Amcor plc (AMCR)

Longboard Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Revenue	13,462	13,640	14,694	14,544	12,861	12,468
Revenue Growth (YoY)	-2.29%	-7.17%	1.03%	13.09%	3.15%	31.82%
Cost of Revenue	10,769	10,928	11,969	11,724	10,129	9,932
Gross Profit	2,693	2,712	2,725	2,820	2,732	2,536
Selling, General & Admin	1,240	1,254	1,244	1,271	1,279	1,371
Research & Development	108	106	101	96	100	97
Other Operating Expenses	-20	78	-8	-54	-83	-35
Operating Expenses	1,328	1,438	1,337	1,313	1,296	1,433
Operating Income	1,365	1,274	1,388	1,507	1,436	1,103
Interest Expense	-341	-364	-274	-159	-157	-207
Interest & Investment Income	37	38	31	24	14	22
Earnings From Equity Investments	-	-4	-	-	19	-14
Currency Exchange Gain (Loss)	-26	-3	-24	-37	-4	21
Other Non Operating Income (Expenses)	-4	-3	-	-1	-1	3
EBT Excluding Unusual Items	1,031	938	1,121	1,334	1,307	928
Merger & Restructuring Charges	-86	-97	-111	-96	-94	-115
Gain (Loss) on Sale of Assets	8	-	215	-	-	-
Asset Writedown	-	-	-	-139	-1	-1
Other Unusual Items	62	62	26	16	-	-1
Pretax Income	1,015	903	1,251	1,115	1,212	811
Income Tax Expense	197	163	193	300	261	187
Earnings From Continuing Operations	818	740	1,058	815	951	624
Earnings From Discontinued Operations	-	-	-	-	-	-8
Net Income to Company	818	740	1,058	815	951	616
Minority Interest in Earnings	-11	-10	-10	-10	-12	-4
Net Income	807	730	1,048	805	939	612
Preferred Dividends & Other Adjustments	2	3	7	3	2	-
Net Income to Common	805	727	1,041	802	937	612
Net Income Growth	23.58%	-30.34%	30.19%	-14.27%	53.43%	42.33%
Shares Outstanding (Basic)	1,441	1,439	1,468	1,509	1,551	1,600
Shares Outstanding (Diluted)	1,445	1,441	1,476	1,516	1,556	1,602
Shares Change (YoY)	0.02%	-2.37%	-2.64%	-2.57%	-2.87%	35.30%
EPS (Basic)	0.56	0.51	0.71	0.53	0.60	0.38
EPS (Diluted)	0.56	0.51	0.70	0.53	0.60	0.38
EPS Growth	23.89%	-28.37%	33.27%	-12.13%	57.59%	5.28%
Free Cash Flow	725	829	735	999	993	984
Free Cash Flow Per Share	0.50	0.57	0.50	0.66	0.64	0.61
Dividend Per Share	0.507	0.500	0.490	0.480	0.470	0.460
Dividend Growth	2.01%	2.04%	2.08%	2.13%	2.17%	1.10%
Gross Margin	20.00%	19.88%	18.55%	19.39%	21.24%	20.34%
Operating Margin	10.14%	9.34%	9.45%	10.36%	11.17%	8.85%
Profit Margin	5.98%	5.33%	7.08%	5.51%	7.29%	4.91%
Free Cash Flow Margin	5.39%	6.08%	5.00%	6.87%	7.72%	7.89%
EBITDA	1,899	1,857	1,956	2,089	2,000	1,733
EBITDA Margin	14.11%	13.61%	13.31%	14.36%	15.55%	13.90%
D&A For EBITDA	534	583	568	582	564	630
EBIT	1,365	1,274	1,388	1,507	1,436	1,103
EBIT Margin	10.14%	9.34%	9.45%	10.36%	11.17%	8.85%
Effective Tax Rate	19.41%	18.05%	15.43%	26.91%	21.54%	23.06%

Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q